Distillate Capital Partners’s Merck MRK Stock Holding History

Distillate Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.5M	Sell	377,115 -69,800	-16%	-$8.17M	2.52%	1
2026 Q1	$53.8M	Buy	446,915 +2,489	+0.6%	+$287K	2.83%	2
2025 Q4	$46.8M	Sell	444,426 -113,557	-20%	-$10.7M	2.41%	2
2025 Q3	$46.8M	Sell	557,983 -7,370	-1%	-$607K	2.43%	3
2025 Q2	$44.8M	Sell	565,353 -58,061	-9%	-$4.62M	2.4%	2
2025 Q1	$56M	Buy	+623,414	New	+$58.2M	2.87%	2
2023 Q1	–	Sell	-113	Closed	-$12.5K	–	79
2022 Q4	$12.5K	Buy	+113	New	+$11.6K	1.16%	15

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Distillate Capital Partners's MRK Position: Q2 2026 in Review

Distillate Capital Partners reduced its Merck (MRK) stake by 16% in Q2 2026, selling an estimated $8.17M and leaving 377,115 shares worth $48.5M. The position accounts for 2.52% of the portfolio, ranked #1.

Distillate Capital Partners first reported a position in MRK in Q4 2022 and has held it in 7 quarters since. The position peaked at $56M in Q1 2025. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Distillate Capital Partners held 377,115 shares of Merck worth $48.5M as of Q2 2026.
Distillate Capital Partners sold 69,800 Merck shares in Q2 2026, an estimated $8.17M.
Merck made up 2.52% of Distillate Capital Partners's portfolio in Q2 2026, its #1 holding.
Distillate Capital Partners first reported a position in Merck in Q4 2022 and has held it in 7 quarters since.
Distillate Capital Partners's Merck position peaked at $56M in Q1 2025.
3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.